We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
NVR
NVR
$17.2B
| $1.98M | 0.03% |
486
-1,580
| -76% | -$6.1M |
|
652
AstraZeneca
AZN
$263B
| $1.98M | 0.03% |
18,066
-32,353
| -64% | -$3.6M |
|
653
Arcus Biosciences
RCUS
$3.57B
| $1.97M | 0.03% |
115,163
-44,636
| -28% | -$997K |
|
|
JKS
654
JinkoSolar
JKS
$775M
| $1.97M | 0.03% |
+49,588
| New | +$1.14M |
|
655
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.97M | 0.03% |
25,866
-43,736
| -63% | -$4.43M |
|
656
MKS Inc
MKSI
$22.2B
| $1.96M | 0.03% |
17,962
-2,964
| -14% | -$347K |
|
657
Park Hotels & Resorts
PK
$2.97B
| $1.96M | 0.03% |
+196,149
| New | +$1.86M |
|
658
MillerKnoll
MLKN
$1.5B
| $1.95M | 0.03% |
64,793
+29,321
| +83% | +$726K |
|
659
Kohl's
KSS
$2.03B
| $1.95M | 0.03% |
105,112
-164,320
| -61% | -$3.48M |
|
660
Datadog
DDOG
$87.9B
| $1.94M | 0.03% |
+19,027
| New | +$1.66M |
|
661
Gentex
GNTX
$4.88B
| $1.94M | 0.03% |
75,430
+63,634
| +539% | +$1.69M |
|
662
National Beverage
FIZZ
$2.87B
| $1.93M | 0.03% |
56,858
-8,746
| -13% | -$306K |
|
663
Vistra
VST
$55.1B
| $1.92M | 0.03% |
101,632
-2,327
| -2% | -$43.9K |
|
664
La-Z-Boy
LZB
$1.59B
| $1.92M | 0.03% |
60,591
+26,255
| +76% | +$798K |
|
665
State Street SPDR S&P Retail ETF
XRT
$365M
| $1.91M | 0.03% |
38,531
-144,912
| -79% | -$7.1M |
|
|
SHOE
666
Shoe Station Group
SHOE
$395M
| $1.91M | 0.03% |
113,646
+70,326
| +162% | +$1.06M |
|
667
Perdoceo Education
PRDO
$1.9B
| $1.91M | 0.03% |
+155,709
| New | +$2.26M |
|
668
InterDigital
IDCC
$6.68B
| $1.9M | 0.03% |
33,233
-32,731
| -50% | -$1.97M |
|
|
DRE
669
DELISTED
Duke Realty Corp.
DRE
| $1.9M | 0.03% |
51,354
-96,888
| -65% | -$3.65M |
|
670
iShares Russell 2000 ETF
IWM
$80.9B
| $1.89M | 0.03% |
12,598
-29,249
| -70% | -$4.4M |
|
671
Gartner
IT
$9.41B
| $1.87M | 0.03% |
14,953
-36,186
| -71% | -$4.6M |
|
|
VSLR
672
DELISTED
VIVINT SOLAR, INC.
VSLR
| $1.86M | 0.03% |
43,890
-5,309
| -11% | -$137K |
|
673
First Financial Bankshares
FFIN
$4.97B
| $1.85M | 0.03% |
66,437
-85,188
| -56% | -$2.52M |
|
674
Incyte
INCY
$23.5B
| $1.85M | 0.02% |
+20,614
| New | +$1.99M |
|
675
Tandem Diabetes Care
TNDM
$1.17B
| $1.84M | 0.02% |
16,256
+1,364
| +9% | +$143K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.